104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain.
No Thumbnail Available
Identifiers
Date
2021-09-27
Authors
Pereyra-Rodriguez, Jose Juan
Dominguez-Cruz, Javier
Armario-Hita, Jose Carlos
Ruiz-Villaverde, Ricardo
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Antibodies, Monoclonal, Humanized
Dermatitis, Atopic
Dermatology
Double-Blind Method
Humans
Severity of Illness Index
Spain
Treatment Outcome
Dermatitis, Atopic
Dermatology
Double-Blind Method
Humans
Severity of Illness Index
Spain
Treatment Outcome